Drägerwerk AG & Co. KGaA (DRWKF)
- Previous Close
47.64 - Open
51.19 - Bid --
- Ask --
- Day's Range
51.19 - 51.19 - 52 Week Range
44.66 - 51.19 - Volume
121 - Avg. Volume
0 - Market Cap (intraday)
947.926M - Beta (5Y Monthly) -0.17
- PE Ratio (TTM)
8.93 - EPS (TTM)
5.73 - Earnings Date Jul 25, 2024
- Forward Dividend & Yield 1.97 (3.85%)
- Ex-Dividend Date May 9, 2024
- 1y Target Est
--
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
www.draeger.comRecent News: DRWKF
Performance Overview: DRWKF
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRWKF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRWKF
Valuation Measures
Market Cap
973.33M
Enterprise Value
1.02B
Trailing P/E
8.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.27
Price/Book (mrq)
0.62
Enterprise Value/Revenue
0.28
Enterprise Value/EBITDA
5.91
Financial Highlights
Profitability and Income Statement
Profit Margin
3.00%
Return on Assets (ttm)
3.14%
Return on Equity (ttm)
7.40%
Revenue (ttm)
3.35B
Net Income Avi to Common (ttm)
100.48M
Diluted EPS (ttm)
5.73
Balance Sheet and Cash Flow
Total Cash (mrq)
211.7M
Total Debt/Equity (mrq)
19.93%
Levered Free Cash Flow (ttm)
178.8M
Research Analysis: DRWKF
Company Insights: DRWKF
DRWKF does not have Company Insights